By Hanna Vioque ( December 3, 2025, 5:20 PM GMT) -- Abbott has denied Sinocare's claims that its patents are invalid and asserted that the use of several screen features provided benefits to device users, accusing its rival once more of selling glucose monitors that infringe its intellectual property....

See Full Page